Author

Matthew Surface

Columbia University Irving Medical CenterORCID 0000-0002-4933-2618Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Neuroscience· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:statistical model· 2 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:proteomics· 1 Research Focus:variant calling· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Roy N. AlcalayiD· 3 shared Alberto Javier EspayiD· 1 shared Alessio Di FonzoiD· 1 shared Alice KaganovichiD· 1 shared Cheryl WatersiD· 1 shared Dan SpiegelmaniD· 1 shared Edward A. FoniD· 1 shared Elena ZivianiiD· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersNeuroscience

Roy N. AlcalayORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Neurosciencenpj Parkinson s DiseasePeer-reviewedJul 19, 2022

The activities of LRRK2 and GCase are positively correlated in clinical biospecimens and experimental models of Parkinson's disease

Maria Kedariti, Emanuele Frattini, Pascale Baden…·Nicoletta Plotegher

The paper investigates the relationship between LRRK2 and GCase activities in Parkinson's disease models and biospecimens, finding a positive correlation.

45 citationstop 3%

humanexperimental assay

𝕏 PostBluesky

Systems BiologyEMBO Molecular MedicinePeer-reviewedJan 22, 2021

Urinary proteome profiling for stratifying patients with familial Parkinsons disease

Sebastian Virreira Winter, Özge Karayel, Maximilian T. Strauss…·Matthias Mann

This study uses urinary proteomics and machine learning to identify biomarkers for stratifying Parkinson's disease patients and LRRK2 mutation carriers.

152 citationstop 1%

humanproteomics

𝕏 PostBluesky

Genetic & Genomic MedicineMovement DisordersPeer-reviewedSep 24, 2020

Analysis of heterozygous PRKN variants and copy number variations in Parkinson's disease

Eric Yu, Uladzislau Rudakou, Lynne Krohn…·Ziv Gan‐Or

This study examines the association between heterozygous PRKN variants and Parkinson's disease risk and onset, finding no significant associations.

46 citationstop 5%

humanwhole-exome sequencing

𝕏 PostBluesky